DOI: http://dx.doi.org/10.18203/issn.2454-2156.IntJSciRep20205489

Drug therapy and cost analysis of urinary tract infections in a tertiary care teaching hospital in Nepal

Naba Raj Bastola, Sagarananda Giri, Kushal Subedi, Bipindra Pandey, Bibek Adhikari, Renu Karki

Abstract


Background: Urinary tract infection (UTI) is the most common infection caused by the presence and growth of pathogenic microorganisms within the human urinary system into the lower and upper genito-urinary tract. UTI continues to be major health problems in developing countries like Nepal.

Methods: A prospective observational study was conducted from June 2019 to November 2019 in the outpatient and inpatient department of Manipal teaching hospital. The face-to-face interview was adopted in 137 UTI patients with the census sampling technique.  

Results: A total of 137 patients (121 out-patients and 16 in-patients), 82 (59.85%) female, and 55 (40.15%) males were enrolled in which UTI was observed in more than half of the sample in the aged group of 25-54. Escherichia coli was the most common uropathogens isolated whereas dysuria was the most common presenting symptom among the patients. Cefixime 200 mg followed by nitrofurantoin 100 mg was the most commonly prescribed medicine for UTI. Disodium hydrogen 1.40 g oral liquid, pantoprazole 40 mg tablet, and multivitamins were commonly prescribed supportive medications. The empirically prescribed average cost was Nepalese rupee (NRs.) 820.44 whereas the total definitive average cost was NRs. 305.54. The average cost of medical management for in-patients was NRs. 2316.55 including registration, urine analysis, investigation bed charge, and other consumable charges as well as discharge medicine cost.

Conclusions: With lower cost, higher sensitivity, and high prescription, cefixime, and nitrofurantoin could be better drugs for the management of UTI among outpatient department (OPD) patients while ceftriaxone could be better for in-patients.

 


Keywords


Urinary tract infections, Drug therapy, Cost analysis, Antimicrobial susceptibility pattern

Full Text:

PDF

References


Anejo-Okopi AJ, Okwori AE, Eze MI, Onaji AI, Ali M, Adekwu A, Ejiji IS. Prevalence and Antibiotic Resistance Pattern of Urinary Tract Bacterial Infections among Symptomatic Patients Attending University of Maiduguri Teaching Hospital, North East Nigeria. Eur J Adv Res Biol Life Sci. 2015;3(3):31-41.

Abubakar EM. Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa state, Nigeria. J Clin Med Res. 2009;1(1):1-8.

Vallejo-Torres L, Pujol M, Shaw E, Wiegand I, Vigo JM, Stoddart M, et al. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the combacte-magnet, rescuing study. BMJ Open. 2018;8(4).

Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(1):5-13.

Akhtar N, Rahman R, Sultana S, Rahman MR. Antimicrobial sensitivity pattern of bacterial pathogens associated with urinary tract infection. Delta Med Col J. 2017;5(2):57-62.

Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, editors. Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier Saunders; 2014.

Gupta UP, Jaiswal S, Thapa L, Parajuli N, Nepali S. Prevalence of Urinary Tract Infection among Suspected Female Patients Attending Manipal Teaching Hospital, Pokhara, Nepal. Res & Rev: J Microbiol Virol. 2013;3(2):1-10.

Al-Jebouri MM, Mdish SA. Antibiotic resistance pattern of bacteria isolated from patients of urinary tract infections in Iraq. Open J Urol. 2013;3(2):1-8.

Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother. 2000;45(3):295-303.

Sedighi I, Solgi A, Amanati A, Alikhani MY. Choosing the correct empirical antibiotic for urinary tract infection in pediatric: Surveillance of antimicrobial susceptibility pattern of Escherichia coli by E-Test method. Iranian J Microbiol. 2014;6(6):387.

Jha N, Bapat SK. A study of sensitivity and resistance of pathogenic microorganisms causing UTI in Kathmandu valley. Kathmandu University Med J (KUMJ). 2005;3(2):123-9.

Sah SK, Regmi S, Upreti AR, Pathak S. Antibiotic resistance patterns and evaluation of treatment in out-patients with urinary tract infections in Nepal. Int J Pharm Sci Res. 2016;7(11):4626.

Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF. Prevalence of urinary tract infections (UTI) among patients attending DalhatuAraf Specialist Hospital, Lafia, Nasarawa state, Nigeria. Int J Med Med Sci. 2010;1(5):163-7.

Prakasam KA, Kumar KD, Vijayan M. A cross sectional study on distribution of urinary tract infection and their antibiotic utilisation pattern in Kerala. Int J Pharm Tech Res. 2012;4(3):1310-6.

Paudel L, Manandhar N, Sah S, Khadka S, Neupane S, Joshi SK. Prevalence of urinary tract infection and associated risk factors among women in Sindhupalchowk district, Nepal. Int J Comm Med Public Health. 2018;5:2714-9.

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):103-20.